glp-1 agonist dopamine Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review

GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes

26.94

★★★★☆4.8 (126)

An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking

23.68

★★★★★4.9 (98)

Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels

22.14

★★★★★5.0 (157)

Weight Loss Drugs May Impact Brain Reward System. Researchers have raised concerns that new-generation weight loss medications may directly affect the brain's pleasure and reward system in addition to reducing appetite. Recent

26.47

★★★★★4.7 (84)

GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity: Cell Reports

23.67

★★★★★4.9 (203)

GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal

21.55

★★★★★5.0 (176)

From metabolism to mind: The expanding role of the GLP-1 receptor in neurotherapeutics

27.13

★★★★★4.8 (132)